Sort   by:  
 Page size 
To study mechanisms of neurodegenerative diseases, neuronal cell lines are important model systems and are often differentiated into postmitotic neuron-like cells to resemble more closely primary neurons obtained from brains. One such cell line is the Lund Human Mesencephalic (LUHMES) cell line whic...
ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse) 
2020-09-24 | PXD020044 | Pride
LUHMES cells share many characteritics with human dopamingeric neurons in the substantia nigra, the cells whose demise is responsible for the motor symptoms in Parkinson’s disease (PD). LUHMES cells can therefore be used bona fide as a model to study pathophysiological processes involved in PD. Prev...
ORGANISM(S): Homo sapiens (Human) 
2022-05-19 | PXD028322 | Pride
we performed lentiviral CRISPR interference (CRISPRi) by recruiting dCas9 fused with the KRAB domain to the CSMD1 enhancer (fam3) in the neuronal precursor cell line – Lund human mesencephalic (LUHMES). Given that the expression of CSMD1 was not detectable in LUHMES cells we differentiated these cel...
ORGANISM(S): Homo sapiens 
Transcriptome and proteome analysis in LUHMES cells overexpressing alpha-synuclein
Over one-third of human lysine methyltransferases (KMTs) and lysine demethylases (KDMs), the enzymes responsible for adding or removing methylation on lysine residues within proteins, are linked to neurodevelopmental disorders (NDDs). Consequently, several studies have explored the roles of specific...
ORGANISM(S): Homo sapiens (Human) 
2026-10-02 | PXD069591 | Pride
LUHMES cells are non-tumorigenic model of human dopaminergic neurons. Their physiology and phenotypic changes upon differentiation can provide clues into the pathology of neurological diseases such as dyslexia, autism, schizophrenia.
ORGANISM(S): Homo sapiens 
RNA-seq of CSMD1 enhancer CRISPRi in LUHMES cells and differentiated neurons
Differential transcriptome analysis in LUHMES cells overexpressing human wild-type alpha-synuclein or GFP
ORGANISM(S): Homo sapiens 
2022-03-31 | GSE191302 | GEO
Systematic characterization of LUHMES cell-based Parkinson’s disease models reveals potential novel drug targets.
Characteriration of mitochondrial stress response in Luhmes-derived dopaminergic neurons Comparative expression profile using RNAseq after 8 hours of Antimycin + Oligomycin treatment in differentiated Luhmes cells
Sort   by:  
 Page size